News

Learning from microalgae as ‘biofactories’

In a newly published research, former members of the Price lab Saheed Imam and Sascha Schäuble, in collaboration with the Baliga lab, share discoveries from their studies of Chlamydomonas reinhardtiiChlamy for short. What follows is a short excerpt:

To the casual observer, algae may appear to be a nuisance. But for researchers, photosynthetic microalgae and other microbes have the potential to become sustainable biofactories that can economically produce renewable biofuels and a wide variety of other valuable commodities. One such group of microalgae is Chlamydomonas reinhardtiiChlamy for short. In an effort to better understand the gene regulatory and metabolic networks of this single-celled alga, researchers at Institute for Systems Biology studied the changes in Chlamy’s genetics and metabolism that cause them to capture and store carbon dioxide.

Read the full article on the ISB website…

Recent Articles

  • A New Approach to Alzheimer’s Disease

    The impact of Alzheimer’s Disease is staggering – 6 million Americans diagnosed, a financial toll of $600 billion annually, and no effective drug treatments. ISB Co-founder Dr. Lee Hood said the traditional approach isn’t working, and we need to think about it in brand new ways.

  • David Sinclair On Why We Age — And Why We Don’t Have To

    Dr. David Sinclair, a Harvard Medical School professor and New York Times bestselling author, was the guest of honor for the ISB-Town Hall Science Series on Thursday. He joined genomics pioneer and ISB Co-founder Dr. Lee Hood for a conversation that covered the very latest in aging research.

  • NYT Illustration

    ISB Research on the Aging Microbiome Featured in The New York Times

    ISB’s research into the aging microbiome was featured in a story published by Anahad O’Connor for The New York Times titled “A Changing Gut Microbiome May Predict How Well You Age.” The research featured was published in Nature Metabolism by Drs. Tomasz Wilmanksi, Noa Rappaport, Sean Gibbons and Nathan Price.